Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

This study has been completed.
Sponsor:
Information provided by:
ACADIA Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT00361166
First received: August 3, 2006
Last updated: March 20, 2007
Last verified: March 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given